Analysis of Ebola Virus Entry into Macrophages

Journal of Infectious Diseases

Volumn 212, Issue , 2015, Pages S247-S257

  Dahlmann, Franziska ^a   Biedenkopf, Nadine ^b   Babler, Anne ^c   Jahnen Dechent, Willi ^c   Karsten, Christina B ^a,d   Gnirß, Kerstin ^a   Schneider, Heike ^e   Wrensch, Florian ^a   O'Callaghan, Christopher A ^g   Bertram, Stephanie ^a   Herrler, Georg ^f   Becker, Stephan ^b   Pöhlmann, Stefan ^a   Hofmann Winkler, Heike ^a  

^a GERMAN PRIMATE CENTER   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c RWTH AACHEN UNIVERSITY   (Germany)

^d Institutes for Cellular Chemistry   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^g UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Ebolavirus; entry; macrophage; Mer; NPC 1

Indexed keywords

ALPHA5 INTEGRIN; AXL PROTEIN; CARRIER PROTEIN; CD209 ANTIGEN; KIDNEY INJURY MOLECULE 1; LECTIN; MER PROTEIN; NIEMANN PICK C1 PROTEIN; PROTEIN TYROSINE KINASE; SCAVENGER RECEPTOR A; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; GLYCOPROTEIN; VIRULENCE FACTOR;

ARTICLE; CONTROLLED STUDY; EBOLAVIRUS; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL; VIRUS ENTRY; CELL LINE; EBOLA HEMORRHAGIC FEVER; HEK293 CELL LINE; METABOLISM; PATHOGENICITY; VIROLOGY;

CELL LINE; EBOLAVIRUS; GLYCOPROTEINS; HEK293 CELLS; HEMORRHAGIC FEVER, EBOLA; HUMANS; LECTINS; MACROPHAGES; VIRULENCE FACTORS; VIRUS INTERNALIZATION;

EID: 84936781995     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv140     Document Type: Article

References (50)

1. Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet 2011; 377:849-62.
2. World Health Organization. Ebola virus disease, West Africa-update. 2014. Available at: URL: http://apps.who.int/ebola/en/ebola-situationreport/ situation-reports/ebola-situation-report. Accessed 26 November-2014.
3. Geisbert TW, Jahrling PB, Hanes MA, Zack PM. Association of Ebolarelated Reston virus particles and antigen with tissue lesions of monkeys imported to the United States. J Comp Pathol 1992; 106:137-52.
4. Le GB, Formenty P, Wyers M, Gounon P,Walker F, Boesch C. Isolation and partial characterisation of a new strain of Ebola virus. Lancet 1995; 345:1271-4.
5. Kuhn JH, Radoshitzky SR, Guth AC, et al. Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor. J Biol Chem 2006; 281:15951-8.
6. Chandran K, Sullivan NJ, Felbor U, Whelan SP, Cunningham JM. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 2005; 308:1643-5.
7. Carette JE, Raaben M, Wong AC, et al. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 2011; 477:340-3.
8. Cote M, Misasi J, Ren T, et al. Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature 2011; 477:344-8.
9. Miller EH, Obernosterer G, Raaben M, et al. Ebola virus entry requires the host-programmed recognition of an intracellular receptor. EMBO J 2012; 31:1947-60.
10. Alvarez CP, Lasala F, Carrillo J, Muniz O, Corbi AL, Delgado R. C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J Virol 2002; 76:6841-4.
11. Simmons G, Reeves JD, Grogan CC, et al. DC-SIGN and DC-SIGNR bind Ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology 2003; 305:115-23.
12. Marzi A, Moller P, Hanna SL, et al. Analysis of the interaction of Ebola virus glycoprotein with DC-SIGN (dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin) and its homologue DCSIGNR. J Infect Dis 2007; 196(suppl 2):S237-46.
13. Takada A, Watanabe S, Ito H, Okazaki K, Kida H, Kawaoka Y. Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry. Virology 2000; 278:20-6.
14. Shimojima M, Takada A, Ebihara H, et al. Tyro3 family-mediated cell entry of Ebola and Marburg viruses. J Virol 2006; 80:10109-16.
15. Hunt CL, Kolokoltsov AA, Davey RA, Maury W. The Tyro3 receptor kinase Axl enhances macropinocytosis of Zaire ebolavirus. J Virol 2011; 85:334-47.
16. Kondratowicz AS, Lennemann NJ, Sinn PL, et al. T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire ebolavirus and Lake Victoria marburgvirus. Proc Natl Acad Sci U S A 2011; 108:8426-31.
17. Freeman GJ, Casasnovas JM, Umetsu DT, DeKruyff RH. TIM genes: A family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity. Immunol Rev 2010; 235:172-89.
18. Nguyen KQ, TsouWI, Kotenko S, Birge RB. TAM receptors in apoptotic cell clearance, autoimmunity, and cancer. Autoimmunity 2013; 46:294-7.
19. Jemielity S, Wang JJ, Chan YK, et al. TIM-family proteins promote infection of multiple enveloped viruses through virion-associated phosphatidylserine. PLoS Pathog 2013; 9:e1003232.
20. Moller-Tank S, Kondratowicz AS, Davey RA, Rennert PD, Maury W. Role of the phosphatidylserine receptor TIM-1 in enveloped-virus entry. J Virol 2013; 87:8327-41.
21. Shimojima M, Ikeda Y, Kawaoka Y. The mechanism of Axl-mediated Ebola virus infection. J Infect Dis 2007; 196(suppl 2):S259-63.
22. Brindley MA, Hunt CL, Kondratowicz AS, et al. Tyrosine kinase receptor Axl enhances entry of Zaire ebolavirus without direct interactions with the viral glycoprotein. Virology 2011; 415:83-94.
23. Morizono K, Xie Y, Olafsen T, et al. The soluble serum protein Gas6 bridges virion envelope phosphatidylserine to the TAM receptor tyrosine kinase Axl to mediate viral entry. Cell Host Microbe 2011; 9:286-98.
24. Gramberg T, Hofmann H, Moller P, et al. LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus. Virology 2005; 340:224-36.
25. Marzi A, Akhavan A, Simmons G, et al. The signal peptide of the ebolavirus glycoprotein influences interaction with the cellular lectins DC-SIGN and DC-SIGNR. J Virol 2006; 80:6305-17.
26. Lin G, Simmons G, Pohlmann S, et al. Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. J Virol 2003; 77:1337-46.
27. Watson AA, Lebedev AA, Hall BA, et al. Structural flexibility of the macrophage dengue virus receptor CLEC5A: implications for ligand binding and signaling. J Biol Chem 2011; 286:24208-18.
28. van de Weyer PS, Muehlfeit M, Klose C, Bonventre JV, Walz G, Kuehn EW. A highly conserved tyrosine of Tim-3 is phosphorylated upon stimulation by its ligand galectin-9. Biochem Biophys Res Commun 2006; 351:571-6.
29. Simmons G, Rennekamp AJ, Chai N, Vandenberghe LH, Riley JL, Bates P. Folate receptor alpha and caveolae are not required for Ebola virus glycoprotein-mediated viral infection. J Virol 2003; 77:13433-8.
30. Kaletsky RL, Simmons G, Bates P. Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity. J Virol 2007; 81:13378-84.
31. Sinn PL, Hickey MA, Staber PD, et al. Lentivirus vectors pseudotyped with filoviral envelope glycoproteins transduce airway epithelia from the apical surface independently of folate receptor alpha. J Virol 2003; 77:5902-10.
32. Chen ST, Lin YL, Huang MT, et al. CLEC5A is critical for dengue-virusinduced lethal disease. Nature 2008; 453:672-6.
33. Marzi A, Gramberg T, Simmons G, et al. DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus. J Virol 2004; 78:12090-5.
34. Cenedella RJ. Cholesterol synthesis inhibitor U18666A and the role of sterol metabolism and trafficking in numerous pathophysiological processes. Lipids 2009; 44:477-87.
35. Wool-Lewis RJ, Bates P. Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. J Virol 1998; 72:3155-60.
36. Geisbert TW, Hensley LE, Larsen T, et al. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am J Pathol 2003; 163:2347-70.
37. Martinez O, Leung LW, Basler CF. The role of antigen-presenting cells in filoviral hemorrhagic fever: gaps in current knowledge. Antiviral Res 2012; 93:416-28.
38. Devitt A, Marshall LJ. The innate immune system and the clearance of apoptotic cells. J Leukoc Biol 2011; 90:447-57.
39. Liao D, Wang X, Li M, Lin PH, Yao Q, Chen C. Human protein S inhibits the uptake of AcLDL and expression of SR-A through Mer receptor tyrosine kinase in human macrophages. Blood 2009; 113:165-74.
40. Rechner C, Kuhlewein C, Muller A, Schild H, Rudel T. Host glycoprotein Gp96 and scavenger receptor SREC interact with PorB of disseminating Neisseria gonorrhoeae in an epithelial invasion pathway. Cell Host Microbe 2007; 2:393-403.
41. Li Y, Mahajan NP,Webster-Cyriaque J, et al. The C-mer gene is induced by Epstein-Barr virus immediate-early protein BRLF1. J Virol 2004; 78:11778-85.
42. Raycroft MT, Harvey BP, Bruck MJ, Mamula MJ. Inhibition of antigen trafficking through scavenger receptor A. J Biol Chem 2012; 287:5310-6.
43. Takada A, Fujioka K, Tsuiji M, et al. Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry. J Virol 2004; 78:2943-7.
44. Morizono K, Chen IS. The role of phosphatidylserine receptors in enveloped virus infection. J Virol 2014; 88:4275-50.
45. Moller-Tank S, Albritton LM, Rennert PD, Maury W. Characterizing functional domains for TIM-mediated enveloped virus entry. J Virol 2014; 88:6702-13.
46. Scott RS, McMahon EJ, Pop SM, et al. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 2001; 411:207-11.
47. Hanayama R, Tanaka M, Miwa K, Shinohara A, Iwamatsu A, Nagata S. Identification of a factor that links apoptotic cells to phagocytes. Nature 2002; 417:182-7.
48. Schornberg KL, Shoemaker CJ, Dube D, et al. α5β1-Integrin controls ebolavirus entry by regulating endosomal cathepsins. Proc Natl Acad Sci U S A 2009; 106:8003-8.
49. Platt N, Suzuki H, Kurihara Y, Kodama T, Gordon S. Role for the class A macrophage scavenger receptor in the phagocytosis of apoptotic thymocytes in vitro. Proc Natl Acad Sci U S A 1996; 93:12456-60.
50. Bermudez LE, Parker A, Goodman JR. Growth within macrophages increases the efficiency of Mycobacterium avium in invading other macrophages by a complement receptor-independent pathway. Infect Immun 1997; 65:1916-25.